Viewing Study NCT04802057


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-27 @ 8:02 AM
Study NCT ID: NCT04802057
Status: TERMINATED
Last Update Posted: 2025-09-11
First Post: 2021-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088
Sponsor: Bioverativ, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module